Intellectual property isn't just protection. It's economic infrastructure.
In the pharmaceutical industry, intellectual property is no longer just an isolated legal instrument. It has become the mechanism that turns knowledge into a strategic asset, capable of attracting investment and generating technological sovereignty.
There's a recurring confusion when we talk about intellectual property. Many people still see IP purely as a legal instrument for protection. In the pharmaceutical industry, that view is outdated.
Intellectual property isn't just protection: it's economic infrastructure. It's the mechanism that turns knowledge into an asset.
From knowledge to asset
A scientific discovery without intellectual protection can generate publications, academic recognition, and advances in knowledge, but it will rarely generate sustainable economic value.
On the other hand, a discovery that is protected, structured, and developed can become a strategic asset, capable of attracting investment, generating licensing, royalties, international partnerships, and industrial development.
This is exactly the point where the conversation about innovation needs to mature.
The value architecture of a molecule
The true value of a molecule lies in the combination of science, intellectual protection, regulatory strategy, and market potential. That is the architecture that determines whether a technology will remain just a scientific discovery or become a global asset.
When we look at the great success stories of the global pharmaceutical industry, we see that the greatest value was not built on scientific excellence alone. It was built on carefully structured assets.
The Brazilian challenge
That's why I believe one of the most important discussions for the future of Brazilian science is how to produce more knowledge and higher-quality intellectual property. Because knowledge generates scientific impact, but well-structured intellectual property generates economic impact, industrial development, and technological sovereignty.
The challenge is ensuring it stays owned by Brazil while generating value for the world. That is the difference between producing knowledge and building technological wealth.
Science generates knowledge.
Intellectual property generates assets.
Assets generate sovereignty.
